Cipla has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a consolidated annual revenue of ₹28,162.59 crore and a net profit of ₹3,861.74 crore. Furthermore, the Board of Directors has recommended a final dividend of ₹13 per equity share for the fiscal year, subject to shareholder approval at the upcoming Annual General Meeting.
Financial Performance Overview
For the financial year ended March 31, 2026, Cipla demonstrated robust performance, reporting consolidated revenue from operations of ₹28,162.59 crore, compared to ₹27,547.62 crore in the previous year. The consolidated net profit for the year stood at ₹3,861.74 crore. For the quarter ended March 31, 2026, the company recorded consolidated revenue of ₹6,541.20 crore with a net profit of ₹542.51 crore.
Dividend and Shareholder Value
The Board of Directors has recommended a final dividend of ₹13 per equity share for the financial year ended March 31, 2026. The record date for the purpose of determining the eligibility of shareholders for this dividend has been fixed as June 5, 2026. The dividend payout is subject to approval by shareholders at the company’s next Annual General Meeting.
Strategic Developments
During the fiscal year, Cipla completed the acquisition of a 100% stake in Inzpera Healthscience Limited for ₹110.65 crore, finalized on December 4, 2025. Furthermore, the company has initiated the process of amalgamating Inzpera Healthsciences Limited with Cipla Limited, following Board approval received on March 19, 2026. Additionally, the company recognized an exceptional item charge of ₹275.91 crore in its consolidated results, primarily due to increased gratuity and leave liabilities arising from changes in labour legislations.
Operating Segments
Following a change in the Chief Operating Decision Maker (CODM), the company reassessed its operating structure. As a result, Cipla now operates under a single reportable segment, namely Pharmaceutical and related products, ensuring a more streamlined focus on its core business areas.
Source: BSE
